Literature DB >> 19085767

Von Willebrand factor: another janus-faced hemostasis protein.

Massimo Franchini1, Pier Mannuccio Mannucci.   

Abstract

von Willebrand factor (VWF) is a multimeric plasma protein that mediates platelet adhesion and aggregation at sites of vascular injury and also acts as a protective carrier of factor VIII. Although the acquired or inherited deficiency of VWF is associated with a bleeding tendency, there is increasing evidence that VWF also plays a pivotal role in thrombosis. The presence in plasma of unusually large VWF multimers, due to the congenital or acquired deficiency of the VWF-cleaving metalloproteinase ADAMTS13, has been implicated in the pathogenesis of thrombotic thrombocytopenic purpura. In addition, high plasma levels of VWF have been associated with an increased risk of atherothrombosis. The current article reviews the literature and provides evidence for the two-faced character that VWF therefore represents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19085767     DOI: 10.1055/s-0028-1104545

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  6 in total

1.  O blood group is a risk factor for severe mucosal hemorrhage in orally anticoagulated patients.

Authors:  Massimo Franchini; Chiara Rossi; Carlo Mengoli; Moreno Meschieri; Francesco Frattini; Silvia Crestani; Ivano Giacomini; Mario Luppi; Carlo Bonfanti
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

Review 2.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

3.  Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival.

Authors:  Danwen Qian; Hongliang Liu; Xiaomeng Wang; Jie Ge; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-12-08       Impact factor: 7.396

4.  Effects of plasma glycosyltransferase on the ABO(H) blood group antigens of human von Willebrand factor.

Authors:  Taiki Kano; Kazunao Kondo; Jiharu Hamako; Fumio Matsushita; Kazuya Sakai; Taei Matsui
Journal:  Int J Hematol       Date:  2018-04-04       Impact factor: 2.490

5.  Role of ABO blood type in delayed cerebral ischemia onset and clinical outcomes after aneurysmal subarachnoid hemorrhage in an ethnic minority urban population.

Authors:  Santiago René Unda; Tarini Vats; Rafael De La Garza; Phillip Cezaryirli; David J Altschul
Journal:  Surg Neurol Int       Date:  2020-05-16

6.  Possible race and gender divergence in association of genetic variations with plasma von Willebrand factor: a study of ARIC and 1000 genome cohorts.

Authors:  Zhou Zhou; Fuli Yu; Ashley Buchanan; Yuanyuan Fu; Marco Campos; Kenneth K Wu; Lloyd E Chambless; Aaron R Folsom; Eric Boerwinkle; Jing-fei Dong
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.